Paper219129
Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
Glaser M. J Exp Med, 1979. Cited by 123 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice. Papers, record 219129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/219129
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Cyclophosphamide | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Immunity, Cellular | Major topic |
| Immunosuppression Therapy | Major topic |
| T-Lymphocytes | Major topic |
| Tumor Virus Infections | Major topic |
| Animals | |
| Antigens, Viral | |
| Cell Transformation, Viral | |
| Female | |
| Mice | |
| Simian virus 40 |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 213,615 | Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/213615 | PubMed |
| 2 | 142,792 | Antigen-induced cyclophosphamide-resistant suppressor T cells inhibit the in vitro generation of cytotoxic cells from one-way mixed leukocyte reactions. | J Immunol | 1977 | https://conductscience.org/library/papers/142792 | PubMed |
| 3 | 299,883 | Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. | J Exp Med | 1977 | https://conductscience.org/library/papers/299883 | PubMed |
| 4 | 692,680 | Cyclophosphamide delays 3-methylcholanthrene sarcoma induction in mice. | Nature | 1978 | https://conductscience.org/library/papers/692680 | PubMed |
| 5 | 4,116,319 | The regulatory influence of activated T cells on B cell responses to antigen. | Adv Immunol | 1972 | https://conductscience.org/library/papers/4116319 | PubMed |
| 6 | 4,129,833 | Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40. | J Natl Cancer Inst | 1974 | https://conductscience.org/library/papers/4129833 | PubMed |
| 7 | 4,363,713 | Cellular immunity in mice with simian virus 40-induced mKSA tumors: comparison of three assays of tumor immunity. | J Natl Cancer Inst | 1974 | https://conductscience.org/library/papers/4363713 | PubMed |
| 8 | 4,376,531 | Cell interactions in adoptive immune rejection of a syngeneic tumor. | Int J Cancer | 1974 | https://conductscience.org/library/papers/4376531 | PubMed |
| 9 | 1,080,165 | Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells. | J Immunol | 1975 | https://conductscience.org/library/papers/1080165 | PubMed |
| 10 | 4,583,975 | Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens. | Cancer Res | 1973 | https://conductscience.org/library/papers/4583975 | PubMed |
| 11 | 4,587,740 | A rapid method for the isolation of functional thymus-derived murine lymphocytes. | Eur J Immunol | 1973 | https://conductscience.org/library/papers/4587740 | PubMed |
| 12 | 4,598,645 | T cell control of antibody production. | Contemp Top Immunobiol | 1974 | https://conductscience.org/library/papers/4598645 | PubMed |
| 13 | 4,598,017 | Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. | J Exp Med | 1974 | https://conductscience.org/library/papers/4598017 | PubMed |
| 14 | 4,543,478 | Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4543478 | PubMed |
| 15 | 4,547,522 | B-cell suppression of delayed hypersensitivity reactions. | Nature | 1974 | https://conductscience.org/library/papers/4547522 | PubMed |
| 16 | 4,538,884 | Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. | Immunology | 1972 | https://conductscience.org/library/papers/4538884 | PubMed |
| 17 | 179,019 | Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens. | Nature | 1976 | https://conductscience.org/library/papers/179019 | PubMed |
| 18 | 1,101,472 | The role of specific suppressor T cells in immune tolerance. | Transplant Rev | 1975 | https://conductscience.org/library/papers/1101472 | PubMed |
| 19 | 1,101,468 | Properties of primed suppressor T cells and their products. | Transplant Rev | 1975 | https://conductscience.org/library/papers/1101468 | PubMed |
| 20 | 1,117,258 | Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. | J Exp Med | 1975 | https://conductscience.org/library/papers/1117258 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,701,637 | Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35701637 | PubMed |
| 21,479,313 | Combination approaches to potentiate immune response after photodynamic therapy for cancer. | Photochem Photobiol Sci | 2011 | https://conductscience.org/library/papers/21479313 | PubMed |
| 21,162,652 | Stimulation of anti-tumor immunity by photodynamic therapy. | Expert Rev Clin Immunol | 2011 | https://conductscience.org/library/papers/21162652 | PubMed |
| 18,704,409 | Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. | Cancer Immunol Immunother | 2009 | https://conductscience.org/library/papers/18704409 | PubMed |
| 18,097,448 | Immunological aspects of cancer chemotherapy. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18097448 | PubMed |
| 9,435,316 | Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9435316 | PubMed |
| 6,819,082 | The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6819082 | PubMed |
| 6,788,892 | Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon. | J Exp Med | 1981 | https://conductscience.org/library/papers/6788892 | PubMed |
| 6,460,831 | Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. | J Exp Med | 1982 | https://conductscience.org/library/papers/6460831 | PubMed |
| 6,453,350 | Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6453350 | PubMed |
| 6,332,673 | The use of cytotoxic T cells in the regulation of tumour growth in syngeneic mice. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6332673 | PubMed |
| 6,332,093 | Evaluation of various cytostatic drugs as local immunotherapeutic agents. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6332093 | PubMed |
| 6,313,694 | Inverse relationship between anti-SV40 TASA and anti-H-2 cytotoxic responses. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6313694 | PubMed |
| 6,256,760 | Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species-specific viral oncogenicity. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6256760 | PubMed |
| 6,244,225 | Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. | Infect Immun | 1980 | https://conductscience.org/library/papers/6244225 | PubMed |
| 6,227,381 | Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6227381 | PubMed |
| 3,488,127 | Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan. | Cell Tissue Res | 1986 | https://conductscience.org/library/papers/3488127 | PubMed |
| 3,230,726 | A trial of postoperative adjuvant combination chemo-immunotherapy for stage IV gastric carcinoma. | Jpn J Surg | 1988 | https://conductscience.org/library/papers/3230726 | PubMed |
| 3,156,616 | In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3156616 | PubMed |
| 2,949,833 | In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/2949833 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/219129
GET https://conductscience.org/api/papers/v1/219129/references?page=2